Life Science Company News

Fagron NV: Disclosure of received notification

Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands) 1 , 15 September 2017

Disclosure of received notification
Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received the following notification.

Notification of Alychlo NV and Marc Coucke, received on 13 September 2017

  • On 13 September, Fagron received a notification that the shareholding of Alychlo NV and Marc Coucke, a parent undertaking or a controlling person, had fallen below the disclosure threshold of 15% on 5 September as the result of the disposal of voting securities or voting rights.
  • On the notification date, Alychlo NV and Marc Coucke held a total of 10,749,267 voting rights. 10,742,220 voting rights were held by Alychlo NV and 7,047 voting rights were held by Marc Coucke.
  • Based on the denominator of 71,843,904 (total number of voting rights), in total Alychlo NV and Marc Coucke held on the notification date 14.96% of the total number of voting rights.
  • Alychlo NV is controlled by Marc Coucke.
  • The notification of Alychlo NV and Marc Coucke can be viewed on investors.fagron.com via this link .

In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.


1 This press release was sent out by Fagron NV and Fagron BV.

Please open the link below for the press release:




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Fagron NV via GlobeNewswire

HUG#2134327
By: Nasdaq / GlobeNewswire - 15 Sep 2017
Back to overview

Enhance your business development with Biotechgate